Ofloxacin Treatment for Bacterial Conjunctivitis
Clinical Context and Efficacy
- Ofloxacin 0.3% provides broad-spectrum coverage against common causative organisms, including Staphylococcus epidermidis, Streptococcus pneumoniae, Haemophilus species, and Staphylococcus aureus, and is an effective option for bacterial conjunctivitis, with a complete resolution rate of approximately 75-88% within 7 days, according to the American Academy of Ophthalmology 1
When to Modify Treatment
- If no improvement occurs after 3-4 days of treatment, patients should return for re-evaluation, and consider obtaining conjunctival cultures and sensitivity testing, evaluating for resistant organisms, and assessing for non-bacterial causes, as recommended by the American Academy of Ophthalmology 1, 2
- Patients with severe or moderate bacterial conjunctivitis may require more aggressive initial dosing, and warrant conjunctival cultures before initiating therapy, according to the American Academy of Ophthalmology 2, 3
Important Caveats
- Gonococcal conjunctivitis requires systemic ceftriaxone plus topical therapy, and chlamydial conjunctivitis requires systemic azithromycin or doxycycline, as recommended by the American Academy of Ophthalmology 2
- Risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, advanced age, and recent ocular surgery, and geographic resistance patterns vary, so consider local antibiograms when available, according to the American Academy of Ophthalmology 1, 3
Common Pitfalls to Avoid
- Do not taper antibiotics below 3-4 times daily, as subtherapeutic dosing increases resistance risk, and prolonged antibiotic use causes corneal toxicity, so discontinue once infection resolves, as recommended by the American Academy of Ophthalmology 4
- For contact lens wearers with conjunctivitis, do not patch the eye or use therapeutic contact lenses, as this increases risk of secondary bacterial keratitis, according to the American Academy of Ophthalmology 3